When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Growth hormone deficiency in children

Última revisão: 23 Sep 2025
Última atualização: 17 Apr 2025

Resumo

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • parental consanguinity
  • short stature
  • poor growth velocity
  • short for target height
  • absent pubertal growth spurt ± delayed puberty
  • central nervous system (suprasellar) tumor symptoms
  • symptoms of other pituitary hormone dysfunction
  • characteristic facial appearance
Полная информация

Другие диагностические факторы

  • assisted birth
  • visual impairment
  • associated dysmorphic features
  • focal neurologic deficits
  • hyperphagia/obesity
  • temperature dysregulation/sleep disorder
  • behavioral problems
Полная информация

Факторы риска

  • family history of GHD
  • other pituitary hormone deficiencies
  • central nervous system (CNS) tumors/cysts
  • radiation therapy
  • midline abnormalities
  • CNS infiltrative disorders
  • perinatal complications
  • CNS trauma
  • preexisting iron overload disorder
  • child abuse
  • CNWS infections
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • x-ray wrist
  • thyroid function tests
  • IGF1 and IGFBP3
  • baseline pituitary function tests
  • basic hematology and biochemistry screen
Полная информация

Исследования, проведение которых нужно рассмотреть

  • GH provocation test
  • MRI brain
  • CT brain/x-ray skull
  • full pituitary hormone evaluation
  • specialist referral
  • genetic studies
  • random GH
Полная информация

Алгоритм лечения

Острый

confirmed GH deficiency

Составители

Авторы

Hoong-Wei Gan, BMedSci (Hons), BMBS, MSc, PhD, MRCPCH

Consultant Paediatric Endocrinologist

Great Ormond Street Hospital for Children NHS Foundation Trust

London

UK

Раскрытие информации

HWG is currently taking part in sponsored research (ongoing) for Pfizer Registry of Outcomes In GH Research (PROGRES). HWG has been previously invited to write a review article for The Lancet Diabetes & Endocrinology titled National UK guidelines for the management of paediatric craniopharyngioma for which he received financial compensation. HWG has been invited to give a lecture at the PE Connect Symposium, sponsored by an educational grant from Ipsen Ltd. He is an author of references cited in this topic.

Harshini Katugampola, BSc, MBBS, MSc, PhD, MRCPCH

Consultant Paediatric Endocrinologist

Great Ormond Street Hospital for Children NHS Foundation Trust

London

UK

Раскрытие информации

HK is an author of references cited in this topic.

Выражение благодарностей

Dr Hoong-Wei Gan and Dr Harshini Katugampola would like to gratefully acknowledge Dr Ameeta Mehta, Professor Mehul T. Dattani, and Dr Kyriaki S. Alatzoglou, previous contributors to this topic.

Раскрытие информации

AM is an author of references cited in this topic. MTD received lecture fees from Novo Nordisk, Pfizer, and Ipsen; consultancy fees from Novo Nordisk, Pfizer, Ipsen, and Sandoz; and was a member of a Novo Nordisk advisory board. Novo Nordisk, Pfizer, Ferring, Ipsen, Lilly, Merck, and Serono have made financial contributions to MTD's departmental teaching program. MTD declared that none of these activities are related to this topic. MTD is an author of references cited in this topic. KSA is an author of references cited in this topic.

Рецензенты

Martin Savage, MA, MD, FRCP, MRCPCH

Professor of Paediatric Endocrinology (Emeritus)

Department of Endocrinology

William Harvey Research Institute

St Bartholomew's and the Royal London School of Medicine and Dentistry

John Vane Science Centre

London

UK

Раскрытие информации

MS has received honoraria and consultancy payments from Ipsen, Pfizer, Novo Nordisk, and Merck Serono.

Paul Saenger, MD, MACE

Professor of Pediatrics

Department of Pediatrics (Endocrinology)

Montefiore Medical Center

Albert Einstein College of Medicine

New York

NY

Раскрытие информации

PS declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Hage C, Gan HW, Ibba A, et al. Advances in differential diagnosis and management of growth hormone deficiency in children. Nat Rev Endocrinol. 2021 Oct;17(10):608-24. Аннотация

GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000 Nov;85(11):3990-3.Полный текст  Аннотация

Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86(6):361-97.Полный текст  Аннотация

Yuen KCJ, Biller BMK, Radovick S, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019 Nov;25(11):1191-232.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности